The 2020 Pete Frates Memorial 5K Run/Walk/Wheel will be held virtually and benefit the Healey Center for ALS at Mass General.
Xiqun Chen, MD, Assistant Professor of Neurology, has received a Neuro-immune Interactions award from the ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson’s (ASAP) initiative being implemented through The Michael J. Fox Foundation.
The Sean M. Healey and AMG Center for ALS at Massachusetts General Hospital is proud to offer the Healey Scholars Program, which funds young investigators researching treatments for people living with ALS.
Ghazaleh Sadri-Vakili, PhD has won the Louise Hanson Marshall Special Recognition Award from the Society for Neuroscience. This award honors her work as a leader and mentor who promotes the professional development of women in neuroscience.
Risk score predicts prognosis of outpatients with COVID-19. Risk score predicts prognosis of outpatients with COVID-19. Key Takeaways • During the initial coronoavirus surge, clinicians recognized the need to identify outpatients at greatest risk
The National Academy of Medicine has elected 100 new members, including Merit Cudkowicz, MD, MSc, Chief of Neurology and Director of the Healey Center for ALS at Mass General.
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival.
Mass General Center for TeleHealth Helps Hospitals in New York and Maine Launch TeleStroke Services Within Local Regions
As the demand for virtual health services rapidly increases, the Mass General Center for TeleHealth has implemented a hybrid model in Maine and Glen Falls, New York, enabling organizations to launch their own TeleStroke programs.
Sabrina Paganoni, MD, PhD, co-director, MGH Neurological Clinical Research Institute of Massachusetts General Hospital, was awarded an MDA research grant totaling $500,000 over three years to continue development of the first Platform Trial for ALS.
In addition to helping staff boost their strength and resiliency, Meekins also helps ALS patients cope with their diagnosis, care and end-of-life decisions.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.